Q, S., X, W., C, C., J, L., & Y, W. (2018). Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo. Dove Medical Press.
Chicago Style (17th ed.) CitationQ, Sun, Wang X, Cui C, Li J, and Wang Y. Doxorubicin and Anti-VEGF SiRNA Co-delivery via Nano-graphene Oxide for Enhanced Cancer Therapy in Vitro and in Vivo. Dove Medical Press, 2018.
MLA (8th ed.) CitationQ, Sun, et al. Doxorubicin and Anti-VEGF SiRNA Co-delivery via Nano-graphene Oxide for Enhanced Cancer Therapy in Vitro and in Vivo. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.